Comparative Study between Patients Treated with Conventional Radiotherapy and IMRT with Chemotherapy for Stage III - IVA Nasopharyngeal Carcinoma: A Single Institution Retrospective Report — Oak Academic Publishing
Research ArticleOpen AccessGoogle Scholar indexed
Comparative Study between Patients Treated with Conventional Radiotherapy and IMRT with Chemotherapy for Stage III - IVA Nasopharyngeal Carcinoma: A Single Institution Retrospective Report
Cancer Department of Donka National Hospital, Conakry, Guinea
,
Department of Radiotherapy, The Fourth Affiliated Hospital of Hebei Medical University, Shijiazhuang, China
,
Faculty of Health Sciences and Techniques of Gamal Abdel Nasser University of Conakry, Conakry, Guinea
,
Department of ENT-CFS, Donka National Hospital, Conakry, Guinea
,
Cancer Department of Donka National Hospital, Conakry, Guinea
,
Cancer Department of Donka National Hospital, Conakry, Guinea
,
Cancer Department of Donka National Hospital, Conakry, Guinea
,
Faculty of Health Sciences and Techniques of Gamal Abdel Nasser University of Conakry, Conakry, Guinea
,
Department of Radiotherapy, The Fourth Affiliated Hospital of Hebei Medical University, Shijiazhuang, China
1 Cancer Department of Donka National Hospital, Conakry, Guinea
2 Department of Radiotherapy, The Fourth Affiliated Hospital of Hebei Medical University, Shijiazhuang, China
3 Faculty of Health Sciences and Techniques of Gamal Abdel Nasser University of Conakry, Conakry, Guinea
4 Department of ENT-CFS, Donka National Hospital, Conakry, Guinea
5 Cancer Department of Donka National Hospital, Conakry, Guinea
6 Cancer Department of Donka National Hospital, Conakry, Guinea
7 Cancer Department of Donka National Hospital, Conakry, Guinea
8 Faculty of Health Sciences and Techniques of Gamal Abdel Nasser University of Conakry, Conakry, Guinea
9 Department of Radiotherapy, The Fourth Affiliated Hospital of Hebei Medical University, Shijiazhuang, China
Introduction : Nasopharyngeal carcinomas are the most radiation-sensitive tumours, and radiotherapy alone provides better local control. Objectives : To evaluate the clinical efficacy and acute and late toxicities of two different treatment regimens for locally advanced nasopharyngeal carcinoma. Methods : From 2014 to 2017, 150 cases of stage III and 68 cases of stage IVA nasopharyngeal carcinoma were treated. Of these, 137 received conventional radiotherapy plus chemotherapy, and 81 received intensity-modulated radiotherapy plus chemotherapy. Chemotherapy was given either as induction, concurrent or adjuvant therapy. Survival rates were calculated according to Kaplan Meier and compared with the Log-rank test. The RTOG or EORTC criteria were used to assess acute and late toxicities. Results : The median follow-up time was 21.5 months, and the 2-year locoregional relapse-free survival, distant metastases-free survival, and overall survival rates in the conventional radiotherapy plus chemotherapy group were 76%, 71% and 77%, respectively; in the intensity-modulated radiotherapy plus chemotherapy group, they were 97%, 84%, and 100%, respectively. The difference in survival between the two groups was significant ( χ 2 = 5.06, P = 0.028). The incidence of grade 2 and 3 xerostomia one year after radiotherapy was 45.1% and 30.9% versus 33.3% and 0%. Conclusion : Compared with conventional radiotherapy plus chemotherapy, intensity-modulated radiotherapy plus chemotherapy offers better locoregional relapse-free survival and overall survival in patients with stage III and IVA nasopharyngeal carcinoma, and may significantly reduce the occurrence of radiation-induced xerostomia.
Römer, T., Franzen, S., Kravets, H., et al. (2022) Multimodal Treatment of Nasopharyngeal Carcinoma in Children, Adolescents and Young Adults-Extended Follow-Up of the NPC-2003-GPOH Study Cohort and Patients of the Interim Cohort. Cancers, 14, Article 1261. https://doi.org/10.3390/cancers14051261
Chua, D.T,. Shan, J.S., Wei, W.I., et al. (2001) The Predictive Value of the 2017 American Joint Committee on Cancer Stage Classification in Determining Failure Patterns in Nasopharyngeal Carcinoma. Cancer, 92, 2845-2855. https://doi.org/10.1002/1097-0142(20011201)92:11 3.0.CO;2-7
Yang, J., Liang, Z.G., Jiang, Y.T., et al. (2021) Efficacy and Safety of Concurrent Chemoradiotherapy Combined with Induction Chemotherapy or Adjuvant Chemotherapy in Patients with Stage II-IVA Nasopharyngeal Carcinoma: A Propensity Score Matching Analysis and Meta-Analysis. Frontiers in Oncology, 11, Article 778836. https://doi.org/10.3389/fonc.2021.778836
Hajisafari, A., Bakhshandeh, M., Aghamiri, S.M.R., et al. (2018) A Prospective Evaluation of the Early Effects of Radiation on the Auditory System Frequencies of Patients with Head and Neck Cancers and Brain Tumors after Radiotherapy. Ear, Nose & Throat Journal, 97, E10-E17.
Ameri, A., Norouzi, S., Sourati, A., et al. (2022) Randomized Trial on Acute Toxicities of Weekly vs Three-Weekly Cisplatin-Based Chemoradiation in Head and Neck Cancer. Cancer Research, 5, e1425. https://doi.org/10.1002/cnr2.1425
Afshin, R., Samira, A., Ahmad, A., et al. (2019) A Report of Delayed Toxicities of Intensity Modulated Radiation Therapy for Nasopharyngeal Carcinoma: A Single Center Cross-Sectional Study. International Journal of Cancer Management, 12, e91606.
Ravasco, P., Monteiro-Grillo, I., Marques Vidal, P. and Camilo, M.E. (2005) Impact of Nutrition on Outcome: A Prospective Randomized Controlled Trial in Patients with Head and Neck Cancer Undergoing Radiotherapy. Head & Neck, 27, 659-668. https://doi.org/10.1002/hed.20221
Gordin, A., Golz, A., Daitzchman, M., et al. (2007) Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Imaging in Patients with Carcinoma of the Nasopharynx: Diagnostic Accuracy and Impact on Clinical Management. International Journal of Radiation Oncology, Biology, Physics, 68, 370-376. https://doi.org/10.1016/j.ijrobp.2006.12.028
Au, K.H., Ngan, R.K.C., Ng, A.W.Y., et al. (2018) Treatment Outcomes of Nasopharyngeal Carcinoma in Modern Era after Intensity Modulated Radiotherapy (IMRT) in Hong Kong: A Report of 3328 Patients (HKNPCSG 1301 Study). Oral Oncology, 77, 16-21. https://doi.org/10.1016/j.oraloncology.2017.12.004
Wang, F.H., Wei, X.L., Feng, J., et al. (2021) Efficacy, Safety, and Correlative Biomarkers of Toripalimab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma: A Phase II Clinical Trial (POLARIS-02). Journal of Clinical Oncology, 39, 704-712. https://doi.org/10.1200/JCO.20.02712
Huang, S.H. and O’Sullivan, B. (2017) Overview of the 8th Edition TNM Classification for Head and Neck Cancer. Current Treatment Options in Oncology, 18, Article No. 40. https://doi.org/10.1007/s11864-017-0484-y
Cox, J.D., Stetz, J. and Pajak, T.F. (1995) Toxicity Criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). International Journal of Radiation Oncology, Biology, Physics, 31, 1341-1346. https://doi.org/10.1016/0360-3016(95)00060-C
Gregoire, V., Evans, M., Le, Q.T., et al. (2017) Delineation of the Primary Tumour Clinical Target Volumes (CTV-P) in Laryngeal, Hypopharyngeal, Oropharyngeal and Oral Cavity Squamous Cell Carcinoma: AIRO, CACA, DAHANCA, EORTC, GEORCC,GORTEC, HKNPCSG, HNCIG, IAG-KHT, LPRHHT, NCIC CTG, NCRI, NRG Oncology, PHNS, SBRT, SOMERA, SRO, SSHNO, TROG Consensus Guidelines. Radiotherapy & Oncology, 126, 3-24. https://doi.org/10.1016/j.radonc.2017.10.016
Mu, X., Liu, H., Wu, J., et al. (2022) Induction versus Adjuvant Chemotherapy Combined with Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: A Retrospective Cohort Study. Aging, 14, 6727-6739. https://doi.org/10.18632/aging.204246
Chua, D.T., Sham, J.S., Choy, D., et al. (1998) Preliminary Response of the Asian Oceanian Clinical Oncology Association Randomized Trial Comparing Cisplatin and Epirubicin Followed by Radiotherapy versus Radiotherapy Alone in the Treatment of Patient with Locoregionally Advanced Nasopharyngeal Carcinoma. Cancer, 83, 2270-2283. https://doi.org/10.1002/(SICI)1097-0142(19981201)83:11 3.0.CO;2-T
Zhang, B., Li, M.M., Chen, W.H., et al. (2019) Association of Chemoradiotherapy Regimens and Survival among Patients with Nasopharyngeal Carcinoma: A Systematic Review and Meta-Analysis. JAMA Network Open, 2, e1913619. https://doi.org/10.1001/jamanetworkopen.2019.13619
Fang, L., Shi, L., Wang, W., Hu, T. and Rao, X. (2021) Which Treatment Is Better than Concurrent Chemoradiotherapy about Survival for Stage III or IV Locally Advanced Nasopharyngeal Carcinoma? An Updated Bayesian Network Meta-Analysis of Randomized Controlled Trials. European Archives of Oto-Rhino-Laryngology, 278, 3633-3642. https://doi.org/10.1007/s00405-021-06614-x
Wang, L., Wu, Z., Cheng, W., et al. (2021) Efficacy of Concurrent Chemoradiotherapy in Subgroups of Stage III Nasopharyngeal Carcinoma: An Analysis Based on 10-Year Follow-Up. Radiation Oncology, 16, Article No. 215. https://doi.org/10.1186/s13014-021-01929-9
Huncharek, M. and Kupelnick, B. (2002) Combined Chemotherapy versus Radiotherapy Alone in Locally Advanced Nasopharyngeal Carcinoma. American Journal of Clinical Oncology, 25, 219-223. https://doi.org/10.1097/00000421-200206000-00002
Baujat, B., Audry, H., Bourhis, J., et al. (2006) Chemotherapy in Locally Advanced Nasopharyngeal Carcinoma: An Individual Patient Data Meta-Analysis of Eight Randomized Trials and 1753 Patients. American Journal of Clinical Oncology, 64, 47-56. https://doi.org/10.1016/j.ijrobp.2005.06.037
Tang, L.L., Guo, R., Zhang, N., et al. (2022) Effect of Radiotherapy Alone vs Radiotherapy with Concurrent Chemoradiotherapy on Survival without Disease Relapse in Patients with Low-Risk Nasopharyngeal Carcinoma: A Randomized Clinical Trial. JAMA, 328, 728-736.
Xu, C., Sun, R., Tang, L.L., Chen, L., Li, W.F., Mao, Y.P., Zhou, G.Q., Guo, R., Lin, A.H., Sun, Y., Ma, J. and Hu, W.H. (2018) Role of Sequential Chemoradiotherapy in Stage II and Low-Risk Stage III-IV Nasopharyngeal Carcinoma in the Era of Intensity-Modulated Radiotherapy: A Propensity Score-Matched Analysis. Oral Oncology, 78, 37-45. https://doi.org/10.1016/j.oraloncology.2018.01.008
Chua, D.T., Ma, J., Sham, J.S., et al. (2005) Long-Term Survival after Cisplatin Based Induction Chemotherapy and Radiotherapy for Nasopharyngeal Carcinoma: A Pooled Data Analysis of Two Phase III Trials. Journal of Clinical Oncology, 23, 1059-1060. https://doi.org/10.1200/JCO.2005.12.081
Chen, Y., Liu, M.Z., Liang, S.B., Zong, J.F., Mao, Y.P., Tang, L.L., Guo, Y., Lin, A.H., Zeng, X.F. and Ma, J. (2008) Preliminary Results of a Prospective Randomized Trial Comparing Concurrent Chemoradiotherapy plus Adjuvant Chemotherapy with Radiotherapy Alone in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma in Endemic Regions of China. International Journal of Radiation Oncology, Biology, Physics, 71, 1356-1364. https://doi.org/10.1016/j.ijrobp.2007.12.028
O’Meara, W.P. and Lee, N. (2005) Advances in Nasopharyngeal Carcinoma. Current Opinion in Oncology, 17, 225-230. https://doi.org/10.1097/01.cco.0000156197.29872.8e
Xu, M., Zang, J., Luo, S., Wang, J. and Li, X. (2021) Long-Term Survival Outcomes and Adverse Effects of Nasopharyngeal Carcinoma Patients Treated with IMRT in a Non-Endemic Region: A Population-Based Retrospective Study. BMJ Open, 11, e045417. https://doi.org/10.1136/bmjopen-2020-045417
Zheng, L., Wang, H., Yang, N., Du, F., Xiao, L. and Wu, G. (2022) Research Value of Intensity Modulated Radiation Therapy in Alleviating Parotid Gland Function Injury in Patients with Stage N0 Nasopharyngeal Carcinoma from Physical and Dosimetric Aspects. Computational and Mathematical Methods in Medicine, 2022, Article ID: 4651364. https://doi.org/10.1155/2022/4651364
Wang, Y., Wang, C., He, S., et al. (2022) Induction Chemotherapy Regimen of Docetaxel plus Cisplatin versus Docetaxel, Cisplatin plus Fluorouracil Followed by Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: Preliminary Results of an Open-Label, Noninferiority, Multicentre, Randomised, Controlled Phase 3 Trial. EClinicalMedicine, 53, Article ID: 101625. https://doi.org/10.1016/j.eclinm.2022.101625